These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1980278)

  • 41. Comparative effects of bisoprolol and nitrendipine on exercise capacity in hypertensive patients with regular physical activity.
    Brion R; Carré F; Verdier JC; Poncelet P; Douard H; Page E; Amoretti R; Gauthier J; Ducardonnet A; Gressin V; Dubanchet A
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):78-83. PubMed ID: 10630736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of bisoprolol with nifedipine for treatment of essential hypertension in the elderly: comparative double-blind trial.
    Amabile G; Serradimigni A
    Eur Heart J; 1987 Dec; 8 Suppl M():65-9. PubMed ID: 2967187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiac and vascular beta-adrenoceptor-mediated responses before and during treatment with bisoprolol or atenolol.
    Bolli P; Müller FB; Linder L; Ji BH; Bühler FR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S61-4. PubMed ID: 2439800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute hemodynamic effects of bisoprolol, a new beta 1 selective adrenoreceptor blocking agent, in patients with coronary artery disease.
    Steinmann E; Pfisterer M; Burkart F
    J Cardiovasc Pharmacol; 1986; 8(5):1044-50. PubMed ID: 2429078
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The clinical efficiency and safety of bisoprolol hydrochlorothiazide in patients with mild to moderate essential hypertension].
    Jiang H; Ke YN;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):605-8. PubMed ID: 17081362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative effects of bisoprolol and acebutolol in smokers with airway obstruction.
    Macquin-Mavier I; Roudot-Thoraval F; Clerici C; George C; Harf A
    Br J Clin Pharmacol; 1988 Sep; 26(3):279-84. PubMed ID: 2902873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Investigator's Group.
    Lacourcière Y; Pool JL; Svetkey L; Gradman AH; Larochelle P; de Champlain J; Smith WB
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):454-61. PubMed ID: 9607384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An evaluation of self-measured blood pressure in a study with a calcium-channel antagonist versus a beta-blocker.
    Mengden T; Binswanger B; Weisser B; Vetter W
    Am J Hypertens; 1992 Mar; 5(3):154-60. PubMed ID: 1349485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
    Ollivier JP; Durier P; Bussiere JL; Gayet JL
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S164-6. PubMed ID: 1974509
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long-term treatment.
    Bengtsson C; Johnsson G; Regårdh CG
    Clin Pharmacol Ther; 1975 Apr; 17(4):400-8. PubMed ID: 235398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of bisoprolol and influence on serum thyroid hormones in hyperthyroid patients.
    Pfannenstiel P; Rummeny E; Baew-Christow T; Bux B; Cordes M; Adam W; Panitz N; Pabst J; Disselhoff G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S100-5. PubMed ID: 2439779
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exercise blood pressure and heart rate reduction 24 and 3 hours after drug intake in hypertensive patients following 4 weeks of treatment with bisoprolol and metoprolol: a randomized multicentre double-blind study (BISOMET).
    Haasis R; Bethge H
    Eur Heart J; 1987 Dec; 8 Suppl M():103-13. PubMed ID: 2967183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
    Ruilope LM
    Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of epanolol on intra-arterial ambulatory blood pressure and baroreceptor heart rate reflex in essential hypertension.
    Smith SA; Littler WA
    Clin Exp Pharmacol Physiol; 1988 Apr; 15(4):327-31. PubMed ID: 2908433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carvedilol for systemic hypertension.
    Heber ME; Brigden GS; Caruana MP; Lahiri A; Raftery EB
    Am J Cardiol; 1987 Feb; 59(5):400-5. PubMed ID: 2880498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction.
    Han SW; Choi SW; Ryu KH; Kim HJ; Kim SH; Shim WJ; Cha TJ; Choi DJ; Kim YJ; Yoo BS; Kim JH; Hwang KK; Jeon H; Shin MS
    Cardiovasc Ther; 2016 Jun; 34(3):172-9. PubMed ID: 27003232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.
    Sardina M; Warrington SJ; Boyce M; Johnston A; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S80-90. PubMed ID: 8839231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of bisoprolol with other beta-adrenoceptor blocking drugs.
    Krämer B; Balser J; Stubbig K; Krämer G; Kübler W
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S46-57. PubMed ID: 2439798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.